CONCUR_3A | R Documentation |
Kaplan-Meier digitized data from CONCUR, figure 3A (PMID 25981818). A reported sample size of 243 for a primary endpoint of OS in colorectal cancer.
CONCUR_3A
A data frame of 204 observations and 3 variables:
time | event time (in months) | |
event | PFS event indicator (0 : no event, 1 : event) |
|
arm | treatment arms (placebo, regorafenib) | |
Li J, Qin S, Xu R, et al. Regorafenib plus best supportive care versus placebo plus best supportive care in Asian patients with previously treated metastatic colorectal cancer (CONCUR): a randomised, double-blind, placebo-controlled, phase 3 trial. Lancet Oncol 2015; 16: 619–29.
summary(CONCUR_3A)
kmplot(CONCUR_3A)
Add the following code to your website.
For more information on customizing the embed code, read Embedding Snippets.